Letters, Testimony & Filings Testimony Before the FDA’s Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee Regarding a Hydrocodone-Acetaminophen-Promethazine Combination Product November 2, 2020
Testimony Before the FDA’s Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee Regarding Reformulated Oxycontin September 11, 2020
Letters, Testimony & Filings Supplement to the Petition to the DEA and FDA to Reschedule the Opioid Tramadol From Schedule IV to Schedule II May 28, 2020
Letters, Testimony & Filings Letter to the FDA Urging the Agency Not to Approve the New Drug Application for a Tramadol-Celecoxib Fixed-Dose Combination Product for Management of Acute Pain January 31, 2020
Letters, Testimony & Filings Testimony Before the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee Regarding the Opioid Oxycodegol January 14, 2020
Outrage of the Month: Newly Unsealed Court Documents Shine Light on How Purdue Planned to Mislead Doctors About the Risks of Oxycontin January 1, 2020